One of Its Kind – Vanguard Diagnostic Reagents Manufacturing

Annual Capacity to Manufacture : 7 Million Liters

One of Its Kind – Vanguard's Diagnostic Reagents Manufacturing

Vanguard has an in-house Diagnostic Reagents Manufacturing unit based in Okhla, New Delhi. We are focused towards the development of top-notch in-vitro Diagnostic Reagents and products across the Hematology, Clinical Chemistry, and Immunology segments. Vanguard is an undisputed leader in Immunology Diagnostics & advance clinical Diagnostic Reagents manufacturers list. We are equipped with a formidable development team and high production capacity. We have a state-of-the-art automated Hematology Diagnostic Reagents plant, with an annual capacity of producing 1.5 Million Litres of Diagnostic Reagents per year

Expanding Horizons for Diagnostic Reagents Manufacturering

Vanguard Diagnostics has already doubled the area of its diagnostic reagents manufacturing facility during FY19 in order to meet the increasing production demand for production. Future plans are to build a dedicated area for molecular diagnostics products development and manufacturing. We have also obtained the license to manufacture critical products like HIV, HBsAg and HCV.

We leverage the technical expertise of the team to come up with innovative and customised clinical reagent manufacturing solutions for our customers.

We have introduced world's most stable and reliable Hematology Controls in India. This will enable all sizes of Indian labs to produce results comparable in reliability with International labs.

We target to automate operations so that we could work with a small team of efficient people.

Technology Adoption for Advanced Diagnostic Reagents Production

Vanguard Diagnostics has adopted the Enzyme Linked Immuno Sorbent Assay (ELISA) technology, to develop and successfully launch a test for the detection of Dengue NS1 antigen.
Vanguard Diagnostics is one of the few indigenous manufacturers of this clinic reagents test.
This has facilitated a significant reduction in the cost of the test.
Vanguard Diagnostics developed it's first sterile in the form of Viral Transport Medium.